Dan Zhou
Direktor/Vorstandsmitglied bei Guangzhou Burning Rock Medical Examination Institute Co., Ltd.
Profil
Dan Zhou currently works at Guangzhou Burning Rock Medical Examination Institute Co., Ltd., as Member-Supervisory Board & Sales Vice President.
Aktive Positionen von Dan Zhou
| Unternehmen | Position | Beginn |
|---|---|---|
Guangzhou Burning Rock Medical Examination Institute Co., Ltd.
 Guangzhou Burning Rock Medical Examination Institute Co., Ltd. Medical/Nursing ServicesHealth Services Guangzhou Burning Rock Medical Examination Institute Co., Ltd. is a holding company, which engages in Next-Generation Sequencing (NGS) diagnostics solutions for precision medicine in oncology. Its products are for different cancer types and clinical applications, ranging from companion diagnostics for targeted therapy and immunotherapy, benign or malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction, and tumor susceptibility tests. The company was founded by Han Yu Sheng, Wu Zhi Gang and Chuai Shao Kun on March 18, 2014 and is headquartered in Guangzhou, China. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Guangzhou Burning Rock Medical Examination Institute Co., Ltd.
Guangzhou Burning Rock Medical Examination Institute Co., Ltd. Medical/Nursing ServicesHealth Services Guangzhou Burning Rock Medical Examination Institute Co., Ltd. is a holding company, which engages in Next-Generation Sequencing (NGS) diagnostics solutions for precision medicine in oncology. Its products are for different cancer types and clinical applications, ranging from companion diagnostics for targeted therapy and immunotherapy, benign or malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction, and tumor susceptibility tests. The company was founded by Han Yu Sheng, Wu Zhi Gang and Chuai Shao Kun on March 18, 2014 and is headquartered in Guangzhou, China. | Health Services |
